tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Prokidney Corp options imply 13.0% move in share price post-earnings
PremiumThe FlyProkidney Corp options imply 13.0% move in share price post-earnings
3M ago
Prokidney’s REACT Study: A Promising Step for Kidney Disease Treatment
Premium
Company Announcements
Prokidney’s REACT Study: A Promising Step for Kidney Disease Treatment
3M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
3M ago
ProKidney Secures FDA Alignment for Rilparencel Approval
PremiumCompany AnnouncementsProKidney Secures FDA Alignment for Rilparencel Approval
3M ago
ProKidney announces alignment with FDA on rilparencel accelerated approval path
Premium
The Fly
ProKidney announces alignment with FDA on rilparencel accelerated approval path
3M ago
ProKidney price target raised to $8 from $4 at UBS
Premium
The Fly
ProKidney price target raised to $8 from $4 at UBS
3M ago
ProKidney’s Hold Rating: Balancing Promising Phase 2 Results with Future Uncertainties
PremiumRatingsProKidney’s Hold Rating: Balancing Promising Phase 2 Results with Future Uncertainties
3M ago
Hold Rating for ProKidney Amid Promising Phase 2 Results and Regulatory Uncertainty
Premium
Ratings
Hold Rating for ProKidney Amid Promising Phase 2 Results and Regulatory Uncertainty
3M ago
ProKidney price target raised to $9 from $6 at Citi
Premium
The Fly
ProKidney price target raised to $9 from $6 at Citi
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100